169 related articles for article (PubMed ID: 21259237)
21. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
22. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis.
Jones DS; Irwin CR; Woolfson AD; Djokic J; Adams V
J Pharm Sci; 1999 Jun; 88(6):592-8. PubMed ID: 10350494
[TBL] [Abstract][Full Text] [Related]
24. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
25. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
El-Laithy HM; Shoukry O; Mahran LG
Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658
[TBL] [Abstract][Full Text] [Related]
26. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
Shahzad Y; Khan Q; Hussain T; Shah SN
Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
[TBL] [Abstract][Full Text] [Related]
27. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
28. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
29. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
Song A; Su Z; Li S; Han F
Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of transdermal patches of flurbiprofen with ethyl cellulose.
Idrees A; Rahman NU; Javaid Z; Kashif M; Aslam I; Abbas K; Hussain T
Acta Pol Pharm; 2014; 71(2):287-95. PubMed ID: 25272649
[TBL] [Abstract][Full Text] [Related]
31. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
[TBL] [Abstract][Full Text] [Related]
32. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
[TBL] [Abstract][Full Text] [Related]
33. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen.
Han F; Li S; Yin R; Shi X; Jia Q
Drug Dev Ind Pharm; 2008 Apr; 34(4):453-8. PubMed ID: 18401788
[TBL] [Abstract][Full Text] [Related]
34. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042
[TBL] [Abstract][Full Text] [Related]
35. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil.
Charoo NA; Shamsher AA; Kohli K; Pillai K; Rahman Z
Colloids Surf B Biointerfaces; 2008 Sep; 65(2):300-7. PubMed ID: 18579348
[TBL] [Abstract][Full Text] [Related]
36. Sustained release of intravitreal flurbiprofen from a novel drug-in-liposome-in-hydrogel formulation.
Pachis K; Blazaki S; Tzatzarakis M; Klepetsanis P; Naoumidi E; Tsilimbaris M; Antimisiaris SG
Eur J Pharm Sci; 2017 Nov; 109():324-333. PubMed ID: 28843864
[TBL] [Abstract][Full Text] [Related]
37. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approach.
Moghddam SM; Ahad A; Aqil M; Imam SS; Sultana Y
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):617-624. PubMed ID: 27050533
[TBL] [Abstract][Full Text] [Related]
38. Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.
Li K; Gao S; Tian B; Shi Y; Lv Q; Han J
Curr Drug Deliv; 2018; 15(3):424-435. PubMed ID: 29219057
[TBL] [Abstract][Full Text] [Related]
39. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
Ramkanth S; Chetty CM; Sudhakar Y
Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439
[TBL] [Abstract][Full Text] [Related]
40. Drug-inorganic-polymer nanohybrid for transdermal delivery.
Kim MH; Park DH; Yang JH; Choy YB; Choy JH
Int J Pharm; 2013 Feb; 444(1-2):120-7. PubMed ID: 23357253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
